palbociclib & fulvestrant for breast cancer
Published 5 years ago • 2.9K plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
5:04
paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
-
1:29
capitello-292: capivasertib, palbociclib, and fulvestrant for hr endocrine-resistant breast cancer
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
0:55
fulvestrant plus palbociclib in breast cancer
-
2:56
parsifal-long: fulvestrant and palbociclib vs letrozole and palbociclib
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
1:05
dr. verma on palbociclib plus fulvestrant for hr /her2- breast cancer
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
1:45
real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
2:29
breast cancer: palbociclib in later lines
-
1:56
vepdegestrant palbociclib in er metastatic breast cancer: phase ib trial results
-
5:28
capitello-291: capivasertib fulvestrant for ai-resistant hr /her2- advanced breast cancer
-
1:25
ameera-5: amcenestrant palbociclib for previously untreated er /her2- advanced breast cancer
-
6:20
fulvestrant and palbociclib as first-line treatment for hr /her2- breast cancer
-
7:27
polaris: palbociclib for bipoc patients with her2-negative breast cancer